ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

VivoSim Labs, Inc. (VIVS)

NASDAQ

$1.94

$-0.02

(-1.04%)

VivoSim Labs, Inc. (VIVS) Live Price Chart

Page last updated: 2026-02-12 20:15:00

Key Market Data

Market Cap	$5.06M
Open	$1.92
High	$5.30
Low	$1.41
Previous Close	$1.92
Price Change	$-0.02
Percentage Change	-1.04%
Volume	55K

VivoSim Labs, Inc. (VIVS) Stock Price Today

VivoSim Labs, Inc. (VIVS) is currently trading at $1.94 as of 2026-02-12 20:15:00, reflecting a -1.04% move ($-0.02) from the previous close.

In the short term, the stock has returned -348.26% over the past four weeks. Over the last 12 months, VivoSim Labs, Inc. has recorded a +3.74% price change, indicating a stable performance relative to the broader market.

VivoSim Labs, Inc. (VIVS) 7-Day Stock Price Changes

Over the past seven days, VivoSim Labs, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $2.56 to the latest recorded price of $1.94, reflecting an intraday change of -1.04%. Daily movements highlight shifts in trading volume (54,932), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, VIVS has delivered a -348.26% return over the past month and a +3.74% change in the last 12 months, indicating a stable trend relative to its broader sector peers.

How to Buy VivoSim Labs, Inc. (VIVS)

You can buy and trade VIVS on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for VIVS and Execute Your Trade

Open the trading page, enter VIVS in the search bar, select the amount of VIVS you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is VivoSim Labs, Inc. (VIVS)?

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

VivoSim Labs, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Employees	13
Sector	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Company Website	https://www.organovo.com

Frequently Asked Questions (FAQ)

1.What is the current share price of VivoSim Labs, Inc.?

The latest trading price for VivoSim Labs, Inc. (Common Stock) is $ 1.94, compared with a previous closing price of $ 1.92. That means the stock has moved -1.04% so far today. Intraday price updates and recent trading activity for VIVS can be tracked on the live chart and quote section on this page.

2.Is VivoSim Labs, Inc. stock going up or down?

Looking at recent performances, VIVS has returned -348.26% over the past month, +7.18% over the last six months and +3.74% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for VivoSim Labs, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does VIVS currently sit relative to its 52-week high and low?

In the most recent 52-week period, VivoSim Labs, Inc. has traded between a low of $ 1.41 and a high of $ 5.30. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether VIVS is currently nearer the top or the bottom of its one-year trading band.

4.How is VivoSim Labs, Inc. classified by sector and industry?

VivoSim Labs, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. In practice, this means VivoSim Labs, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing VIVS’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector could influence VivoSim Labs, Inc.’s performance.

5.Where is VivoSim Labs, Inc. listed and how large is it by market value?

VivoSim Labs, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 5.06M, the company is classified as a Small-cap stock. Market cap gives a quick sense of VivoSim Labs, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does VIVS's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.76 summarises how much profit VivoSim Labs, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track VivoSim Labs, Inc.'s financial performance over time?

To follow VivoSim Labs, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how VIVS is performing and how the market is responding.

8.When is VivoSim Labs, Inc. expected to report earnings?

VivoSim Labs, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for VIVS, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in VivoSim Labs, Inc.'s earnings reports?

VivoSim Labs, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether VIVS is meeting, beating or missing expectations.

10.How can I stay informed about VivoSim Labs, Inc.'s results and guidance?

You can stay up to date on VivoSim Labs, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for VIVS on this page helps you see how new information is being reflected in the stock.

11.Does VivoSim Labs, Inc. pay a regular cash dividend to its shareholders?

VivoSim Labs, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor VIVS's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for VIVS?

Based on the latest earnings data, VIVS has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether VivoSim Labs, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings VivoSim Labs, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is VivoSim Labs, Inc.?

VivoSim Labs, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is VIVS valued in terms of P/E ratio and EPS?

VivoSim Labs, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.76. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of VivoSim Labs, Inc.'s earnings. Comparing VIVS's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as VivoSim Labs, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Ambiq Micro, Inc.

AMBQ

Camden Property Trust

CPT

EMCOR Group, Inc.

EME

Essential Properties Realty Trust, Inc.

EPRT

Grindr Inc.

GRND

Top Gainers

Browse today's leading gainers in the US stock market

Brand Engagement Network Inc.

IPG Photonics Corporation

IPGP

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

VIVS-to-USD Calculator

Amount

VIVS

USD

1 VIVS = 1.94 USD